Knockdown of RRBP1 in cancer cells enhances osteoblast differentiation markers (ALP and bone γ-carboxyglutamate protein), matrix mineralization and bone morphogenetic protein (BMP) 2/SMAD1/5/9 activation in pre-osteoblasts (66). The gene discussed is RRBP1; the disease is cancer.